Novo shares jump after Hims drops $49 compounded weight-loss pill
COPENHAGEN, Denmark: Novo Nordisk shares climbed sharply on February 9 after a key source of competitive pressure eased, when telehealth firm Hims & Hers pulled back from selling a low-cost compounded weight-loss pill following regulatory and legal warnings.
Frankfurt-listed shares in Novo Nordisk rose 4.5 percent after Hims & Hers said over the weekend it would revers